Success Metrics

Clinical Success Rate
71.4%

Based on 5 completed trials

Completion Rate
71%(5/7)
Active Trials
2(20%)
Results Posted
60%(3 trials)
Terminated
2(20%)

Phase Distribution

Ph phase_3
2
20%
Ph not_applicable
7
70%
Ph phase_2
1
10%

Phase Distribution

0

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution10 total trials
Phase 2Efficacy & side effects
1(10.0%)
Phase 3Large-scale testing
2(20.0%)
N/ANon-phased studies
7(70.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

71.4%

5 of 7 finished

Non-Completion Rate

28.6%

2 ended early

Currently Active

2

trials recruiting

Total Trials

10

all time

Status Distribution
Active(2)
Completed(5)
Terminated(2)
Other(1)

Detailed Status

Completed5
Active, not recruiting2
Terminated2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
2
Success Rate
71.4%
Most Advanced
Phase 3

Trials by Phase

Phase 21 (10.0%)
Phase 32 (20.0%)
N/A7 (70.0%)

Trials by Status

completed550%
unknown110%
active_not_recruiting220%
terminated220%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
OTHER
Total Trials
10